| text 
Innovation Through Research and Development
Translating good ideas into better products
Innovation is the engine of any business and converts knowledge and ideas into a benefit for the customer and consumer. It all begins with an idea: based on careful observation of laboratory data; on nuggets of information gleaned from mountains of technical literature; on experience and the ability to build on this analysis to reach new conclusions, scientists at Novartis Animal Health develop a working hypothesis. From there, a complex chain of events unfolds that involves hundreds of people around the world in research and development. Novartis Animal Health will push for more innovation, as with a true creative and innovative approach to our products, services and processes we can really make a difference to our customers and their animals.
R&D Sites
BASEL (SWITZERLAND)
Project Management, Chemistry & Bioactive Discovery, Development, Formulation & Analytics, Regulatory Affairs
GREENSBORO (USA)
New Product Development, Drug Safety, Regulatory Affairs
ST. AUBIN (SWITZERLAND)
Parasitology, Veterinary Therapeutics, Bioanalytics, Safety
YARRANDOO (AUSTRALIA)
Bioanalytics, Parasitology, Safety
LARCHWOOD (USA)
Biologicals R&D, Diagnostic Laboratory, Immunology & Virology, Regulatory Affairs
PRINCE EDWARD ISLAND (CANADA)
Aquaculture Vaccines R&D, Microbiology, Process Development, Regulatory Affairs
Partnerships
Novartis collaborates with many companies and academic institutions to develop new products, acquire platform technologies, and access new markets.
Locations
Headquartered in Basel, Switzerland, and present in almost 40 countries, Novartis Animal Health employs approximately 2,600 associates worldwide.